Pipeline - Emerald Health Pharmaceuticals

Skip to content

About
Pipeline
- Pipeline
- Clinical Trials
Technology
Patients
- Patient Information
Investors
Newsroom
Contact

Loading...

Pipeline

PipelineNick Leung2020-06-25T09:55:48-07:00

Product Pipeline

Screen Shot 2020-02-17 at 10.29.10 AM

Learn more about our technology

Loading...

Sign up for our newsletter to stay up-to-date

Sign Up Now

Find us here

Terms & Conditions

I understand and acknowledge that under SEC Regulation A+, no sale may be made to me unless I am either an accredited investor (as defined in the link here), or the purchase price I pay for my investment is less than ten percent (10%) of the greater of my annual income or my net worth, if I am a natural person (not a company). I understand that if I choose to make an investment, and before making any representation in writing that my investment does not exceed the 10% threshold under Regulation A+, the Company strongly recommends that I review Rule 251(d)(2)(i)(C) of Regulation A+ available by clicking the link here.

Securities are offered through Dalmore Group, LLC., a registered broker-dealer and member FINRA/SIPC. Neither Emerald Health Pharmaceuticals Inc. nor Dalmore Group, LLC provide any investment advice or make any investment recommendations to any persons, ever, and no communication through this website or in any other medium should be construed as such.   Emerald Health Pharmaceuticals Inc. securities are not publicly traded and are intended for investors who do not need a liquid investment. This investment is NOT a bank deposit (and thus NOT insured by the FDIC or by any other federal governmental agency), is NOT guaranteed by Dalmore Group, LLC or Emerald Health Pharmaceuticals Inc., and MAY lose value. Investors must be able to afford the loss of their entire investment. Any financial projections or returns shown on the website are illustrative examples only, and there can be no assurance that any valuations provided are accurate or in agreement with market or industry valuations. Investors should conduct their own due diligence, not rely on the financial assumptions or estimates displayed on this website, and are encouraged to consult with a financial advisor, attorney, accountant, and any other professional that can help you to understand and assess the risks associated with any investment opportunity. Please refer to the offering circular for full details and disclosures, including a subscription agreement should you choose to invest.

I understand and acknowledge I must be qualified and the restrictions that apply on who is permitted to invest.

-----

© Emerald Health Pharmaceuticals | All Rights Reserved. | Privacy Policy | Terms of Use

Toggle Sliding Bar Area

Our Regulation A Offering round is currently closed. Click HERE to sign up for future offerings.